A signature pattern of cortical atrophy in dementia with Lewy bodies: A study on 333 patients from the European DLB consortium.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Lemstra, Afina W
Ten Kate, Mara
MetadataShow full item record
CitationA signature pattern of cortical atrophy in dementia with Lewy bodies: A study on 333 patients from the European DLB consortium. 2019, 15(3):400-409 Alzheimers Dement
AbstractWe explored regional brain atrophy patterns and their clinical correlates in dementia with Lewy bodies (DLB). In this multicentre study, we included a total of 333 patients with DLB, 352 patients with Alzheimer's disease (AD), and 233 normal controls and used medial temporal lobe atrophy, posterior atrophy, and frontal atrophy (GCA-F) visual rating scales. Patients were classified according to four atrophy patterns. Patients with DLB had higher scores on all the three atrophy scales than normal controls but had less medial temporal lobe atrophy than those with AD (all P values < .001). A signature hippocampal-sparing pattern of regional atrophy was observed in DLB. The magnetic resonance imaging measures showed 65% ability to discriminate between DLB and AD and marginally contributed to the discrimination over and above the core clinical features. The most common pattern of atrophy of DLB was hippocampal-sparing. Future studies should explore whether comorbid AD pathology underlies the atrophy patterns seen in DLB.
DescriptionTo access publisher's full text version of this article click on the hyperlink below
- Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease.
- Authors: Whitwell JL, Weigand SD, Shiung MM, Boeve BF, Ferman TJ, Smith GE, Knopman DS, Petersen RC, Benarroch EE, Josephs KA, Jack CR Jr
- Issue date: 2007 Mar
- Does posterior cortical atrophy on MRI discriminate between Alzheimer's disease, dementia with Lewy bodies, and normal aging?
- Authors: O'Donovan J, Watson R, Colloby SJ, Firbank MJ, Burton EJ, Barber R, Blamire AM, O'Brien JT
- Issue date: 2013 Jan
- Gray matter atrophy in dementia with Lewy bodies with and without concomitant Alzheimer's disease pathology.
- Authors: van der Zande JJ, Steenwijk MD, Ten Kate M, Wattjes MP, Scheltens P, Lemstra AW
- Issue date: 2018 Nov
- Progressive cortical thinning and subcortical atrophy in dementia with Lewy bodies and Alzheimer's disease.
- Authors: Mak E, Su L, Williams GB, Watson R, Firbank MJ, Blamire AM, O'Brien JT
- Issue date: 2015 Apr
- The influence of hippocampal atrophy on the cognitive phenotype of dementia with Lewy bodies.
- Authors: Elder GJ, Mactier K, Colloby SJ, Watson R, Blamire AM, O'Brien JT, Taylor JP
- Issue date: 2017 Nov
Showing items related by title, author, creator and subject.
Atrophy, ultra-structural disorders, severe atrophy and degeneration of denervated human muscle in SCI and Aging. Implications for their recovery by Functional Electrical Stimulation, updated 2017.Kern, Helmut; Hofer, Cristian; Loefler, Stefan; Zampieri, Sandra; Gargiulo, Paolo; Baba, Alfonc; Marcante, Andrea; Piccione, Francesco; Pond, Amber; Carraro, Ugo; et al. (Taylor & Francis, 2017-07)Long-term lower motor neuron denervation of skeletal muscle is known to result in degeneration of muscle with replacement by adipose and fibrotic tissues. However, long-term survival of a subset of skeletal myofibers also occurs.
Sveinsson chorioretinal atrophy: the mildest changes are located in the photoreceptor outer segment/retinal pigment epithelium junctionJonasson, Fridbert; Sander, Birgit; Eysteinsson, Thor; Jörgensen, Thomas; Klintworth, Gordon K; Department of Ophthalmology, Faculty of Medicine, University of Iceland, Reykjavik, Iceland. firstname.lastname@example.org (Munksgaard, 2007-12-01)PURPOSE: To locate the mildest and/or earliest changes in the retina and/or choroid in Sveinsson chorioretinal atrophy (SCRA), using more advanced techniques than previous studies. METHODS: We used fundus photography, intravenous fluorescein angiography (IVFA) enhanced ocular coherence tomography (OCT) scans, microperimetry and multifocal electroretinography (mfERG) in an attempt to locate the mildest changes in SCRA. Eight patients with SCRA were examined. To improve the resolution of OCT scans, several consecutive recorded B-scans were retrieved for each location of interest. The scans were processed off-line with an averaging algorithm developed to maximally reduce laser speckle (noise). Static microperimetry was performed using the Rodenstock scanning laser ophthalmoscope (SLO). RESULTS: Biomicroscopy and fundus photographs disclosed an apparent thinning of the retinal pigment epithelium (RPE) in the areas minimally affected, where possible changes in the transparent sensory retina were not visible. In minimally affected areas a choriocapillaris filling defect was evident on IVFA, but some choroidal blood vessels remained open. High-resolution OCT scans in normal eyes showed three highly reflective outer layers, probably representing the junction of the inner and outer photoreceptor segments in the case of the innermost layer, the interdigitizing outer photoreceptors and RPE villi in the case of the middle layer, and the outer RPE in the case of the outermost layer. The middle layer was absent in the transition between affected and unaffected areas in all eyes with SCRA. In the more severely affected areas, the innermost layer was discontinuous and associated with increasing thinning of the outermost layer. Microperimetry of the transition areas sometimes showed clearly defined lesions that were non-responsive to stimuli. It also revealed elevated thresholds (10-15 dB) at the margins and normal thresholds in apparently unaffected areas. CONCLUSIONS: The mildest changes seen in SCRA on OCT are found at the outer photoreceptor/RPE junction; the changes in the outer RPE, choriocapillaris and inner photoreceptor segments may be secondary. Corresponding functional deficits are confirmed on microperimetry and mfERG.
Incidence and prevalence of multiple system atrophy: a nationwide study in Iceland.Bjornsdottir, Anna; Gudmundsson, Gretar; Blondal, Hannes; Olafsson, Elias; Univ Hosp, Dept Neurol, Landspitali, IS-108 Reykjavik, Iceland, United Hosp, Dept Pathol, Landspitali, Reykjavik, Iceland, Univ Iceland, Fac Med, Reykjavik, Iceland (Amer Soc Hematology, 2013-02)Multiple system atrophy (MSA) is a neurodegenerative disorder characterised by autonomic dysfunction with parkinsonism (MSAp) or cerebellar (MSAc) symptoms. At autopsy, α-synuclein inclusions in glial cells of the brain are needed to confirm a definite diagnosis. We determined the 10 year incidence of MSA, point prevalence and survival in a well defined population with a high number of neurologists.